IO Biotech Inc

IO Biotech Inc

IOBT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$885.69K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
IO Biotech IncIO Biotech Inc0--9698%-1.6
$0.88

Current Fair Value

7071.5% upside

Undervalued by 7071.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$885,690.00
Enterprise Value$-28,323,310.00
Earnings per Share$-1.45
Beta0.89
Outstanding Shares66,941,964

Return

Return on Equity-9698.02%ROE
Return on Assets-221.12%
Return on Invested Capital-437.64%

Valuation & Multiples

P/E Ratio-0.02P/E Ratio
PEG0.04PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.3
Enterprise Value to Net Income0
Total Debt to Enterprise-0.05
Debt to Equity1.6Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
May 19, 2026
EPS Estimate
$-0.10
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %5.07%▼ 6.66%
Total Invested$199,038▼ 95.84%
Investors Holding12▼ 10.00%

About IO Biotech Inc

IO Biotech Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.